Rasio utang jangka dawa marang modal Vor Bio Inc. (VOR)

This price chart illustrates the price action of Vor Biopharma Inc. (VOR), where the individual long-term debt metric stands at 0.00. The business relies on US laboratories developing cell therapies to protect the body during treatment. Demand for such innovations is independent of economic cycles or seasonality, determined solely by the results of clinical trials. Efficiency is enhanced by outsourcing gene modification to external partners.

This ratio determines the business's dependence on long-term borrowings relative to equity, measuring the company's financial stability and leverage level. By analyzing the historical long-term debt-to-equity ratio, an investor can see the current debt load, which is critically important for Vor Biopharma Inc. (VOR) when financing costly clinical trials and scaling genome editing technologies.